Morepen Laboratories Limited Share Price NSE India S.E.
Stocks
MOREPENLAB
INE083A01026
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.94 INR | -0.69% |
|
+0.85% | +26.42% |
| Market Cap | 1.85TCr 20Cr 17Cr 16Cr 15Cr 28Cr 28Cr 190.04Cr 74Cr 908.72Cr 73Cr 72Cr 3.16TCr | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.85TCr 20Cr 17Cr 16Cr 15Cr 28Cr 28Cr 190.03Cr 74Cr 908.67Cr 73Cr 72Cr 3.16TCr | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | -0.73% | ||
| 1 week | +0.85% | ||
| Current month | +20.07% | ||
| 1 month | +18.76% | ||
| 3 months | +42.05% | ||
| 6 months | +24.81% | ||
| Current year | +26.42% |
| 1 week | 48.6 |  | 53.24 |
| 1 month | 41.38 | | 53.66 |
| Current year | 33.05 | | 53.66 |
| 1 year | 33.05 | | 66.4 |
| 3 years | 28.6 | | 100.9 |
| 5 years | 23.6 | | 100.9 |
| 10 years | 7.2 | | 100.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CEO | Chief Executive Officer | 62 | 01/02/1992 |
| Director of Finance/CFO | 59 | 03/04/2002 | |
| Compliance Officer | 40 | 12/11/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 01/02/1992 |
Sanjay Suri
BRD | Director/Board Member | 57 | 13/08/2019 |
| Director/Board Member | 57 | 13/08/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.69% | +0.85% | - | - | 30Cr | |
| +0.45% | -1.37% | +43.66% | +141.28% | 99TCr | |
| +3.37% | +1.66% | +58.00% | +44.48% | 58TCr | |
| +2.07% | +5.52% | +27.75% | +72.72% | 41TCr | |
| +2.60% | -1.30% | +22.76% | +15.66% | 32TCr | |
| +0.21% | +2.30% | +30.42% | +18.98% | 28TCr | |
| -0.06% | +3.11% | +29.81% | +36.09% | 28TCr | |
| +0.83% | +9.79% | -31.71% | -43.45% | 21TCr | |
| +0.66% | -0.24% | +27.37% | +52.79% | 19TCr | |
| +0.14% | -1.71% | +17.76% | +61.42% | 16TCr | |
| Average | +0.72% | +1.51% | +25.09% | +44.44% | 37.84TCr | |
| Weighted average by Cap. | +1.07% | +0.73% | +33.29% | +66.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.7TCr 18Cr 16Cr 15Cr 14Cr 26Cr 26Cr 174.63Cr 68Cr 835.03Cr 67Cr 66Cr 2.9TCr | 1.81TCr 19Cr 17Cr 15Cr 14Cr 27Cr 28Cr 185.88Cr 72Cr 888.85Cr 72Cr 70Cr 3.09TCr |
| Net income | 96Cr 1.02Cr 89.18L 82.17L 76.92L 1.44Cr 1.47Cr 9.87Cr 3.82Cr 47Cr 3.81Cr 3.73Cr 163.98Cr | 118.02Cr 1.25Cr 1.09Cr 1.01Cr 94.41L 1.77Cr 1.8Cr 12Cr 4.69Cr 58Cr 4.68Cr 4.58Cr 201.26Cr |
| Net Debt | 12Cr 12.72L 11.18L 10.3L 10L 18.07L 18.37L 1.24Cr 47.88L 5.91Cr 47.77L 46.74L 21Cr | -9L -9.8T -8.61T -7.93T -7.42T -13.91T -14.14T -95.22T -36.86T -5L -36.78T -35.98T -15.83L |
Employees
1,814
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | ₹51.94 | -0.69% | 57,03,684 |
| 23/26/23 | ₹52.30 | +4.33% | 1,82,78,357 |
| 22/26/22 | ₹50.13 | +1.27% | 46,97,621 |
| 19/26/19 | ₹49.50 | -3.00% | 61,60,692 |
| 18/26/18 | ₹51.03 | -0.87% | 59,10,588 |
- Stock Market
- Stocks
- MOREPENLAB Stock
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
